67
Views
6
CrossRef citations to date
0
Altmetric
Letter

Nalmefene and alcohol dependence: A new approach or the same old unacceptable marketing?

&
Pages 75-80 | Published online: 29 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alain Braillon & Bernard Granger. (2016) Disclosure of conflicts of interest and credibility for the medical profession. Substance Abuse and Rehabilitation 7, pages 1-2.
Read now
Michael Soyka. (2016) Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential. Expert Opinion on Pharmacotherapy 17:4, pages 619-626.
Read now

Articles from other publishers (4)

Alain Braillon, Francoise Taiebi & Amal Bernoussi. (2018) Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?. Clinical Drug Investigation 38:4, pages 385-386.
Crossref
Alain Braillon. (2016) Treatment of alcohol use disorders in patients with liver disease. Journal of Hepatology 65:6, pages 1270.
Crossref
Alain Braillon. (2016) Comment on: “Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence”. Drug Safety 39:11, pages 1151-1152.
Crossref
Alain Braillon. (2016) Recommendations of French Alcohol Society and European Federation of Addiction Societies. CNS Neuroscience & Therapeutics 22:6, pages 535-536.
Crossref